Dibenzosuberone (10,11-Dihydrodibenzo[a,d]cyclohepten-5-one)
Synonyma:Dibenzosuberone10,11-Dihydro-5H-; 10,11-dihydro-dibenzo [a, d] cyclohepten-5-una DES; 10,11-Dihydrodibenzo[a, d] cycloheptanone; 10,11-Dihydrodibenzo[a, d] cyclohepten-5-one.
CAS No.:1210-35-1
Formulae hypotheticae:C15H12O
Pondus hypotheticum:208.26
EINECS No.:214-912-3
Applicatio:Pharmaceuticalia, media, APIs, consuetudo, synthesis, oeconomia
Structure
Praelatio:Sansoni, Quality, Auctor Price, Fast Delivery, Velox Responsio.
Utitur:Medium pharmaceuticum, pro synthesi Amitriptylini.
Genera cognata:FunctionMaterials; Triticum aestivum; PharmaceuticalIntermedias; Aromata; Immunditia; Intermedia&FineChemicals; Pharmaceuticals; C15toC38; CarbonylCompounds; ChemicalSynthesis; Ketones; OrganicBuildingBlocks; Aromata, Impurities, Pharmaceutical, Intermedia & FineChemicals.
punctum liquescens | 32-34 °C (lit.) |
fervens | 148 °C0.3 mm Hg(lit.) |
Densitas | 1.156 g/mL ad 25 °C(lit.) |
Refractivus index | n20/D 1.6332(lit.) |
Repono conditione | Serva in caliginoso loco, atmosphaeram Inertissimam, cubiculum temperatum |
Solubilitas | 0.03g/l |
Forma | Liquid vel Maximum solidum ustio |
Flash punctus | >23 °F |
Color | Patet flavo |
Aqua solutionis | Insolubilis |
Numerus aleam Code | 36/37/38 |
Salus Denunciationes | 24/25-36-26 |
WGK Germania | 3 |
RTECS | HP1149700 |
TSCA | Ita |
HS Code* | 29143900 |
Speciales determinationes secundum elit elit | |
Aspectus | Lumine flavo oleum liquidum vel solidum |
Aquae | 0.5%max |
Munditia (HPLC) | 99.0%min |
Cautiones pro tutum pertractatio;
Bene ventilatas tractantem in loco. Apta tutela vestitus. Fuge contactum cum cute et oculis. Fuge formationem pulveris et aerosols. Utere instrumentis non-noctis. Ne ignis per electrostatic missionem vaporis.
Condiciones pro repono, quaslibet incompatibiles:
Repone continens arcte clausum in loco sicco, frigido et bene ventilato. Disponunt a vasis cibi vel materiae repugnantes.
Jingye habet 86 reactoria in summa, quorum volumen electri reactor est 69, ab 50 ad 3000L. Numerus reactorum immaculatorum est 18, ab 50 ad 3000L. QC centenariis omnium instrumentorum analyticorum instruitur. Ad productionem commercialem et analysim comprehendendam producti occurrere potest. Hoc productum est productum macula superior et tradi potest secundum necessitates Lorem.
Jiangsu Jingye Pharmaceutical Co, Ltd., olim Jintan Depei Chemical Co, Ltd. nominatus est, qui anno 1994 instituit, et ad fabricam pharmaceuticam professionalem anno 2016. Post duo decennia evolutionis Jingye pharmaceutica ad professionalem et comprehensivam pharmaceuticam crevit. inceptum coniungendo R&D, productionem, importationem et exportationem cum duobus subsidiariis in Shanghai et Lianyungang sitis.